Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

ABSTRACT Background Once‐daily basal insulin is widely used in the management of type 2 diabetes, but poor adherence to daily injections often impairs glycaemic control. Once‐weekly efsitora alfa may overcome these limitations, but pooled data assessing its comparative efficacy and safety remain lim...

Cijeli opis

Bibliografski detalji

Glavni autori:	Harris Mehmood, Moaz Alowami, Thel Su Hlaing, Khant Nyi Zaya, Yousrah Uraiby, Ahmed Muaaz Alam, Abubakr Adala, Osama Ikram, Syed Faisal Ali, Muzammil Farhan, Eeshal Zulfiqar, Mushood Ahmed, Raheel Ahmed, Ammara Naeem
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-11-01
Serija:	Endocrinology, Diabetes & Metabolism
Teme:	basal insulin Fc daily basal insulin diabetes efsitora type‐2 diabetes weekly insulin
Online pristup:	https://doi.org/10.1002/edm2.70126
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!